FindTrial
Sign In

Clinical observation of continuous pumping dexmedetomidine + remifentanil and continuous pumping dexmedetomidine + sufentanil for sedation, analgesia and anesthesia

Clinical observation of continuous pumping dexmedetomidine + remifentanil and continuous pumping dexmedetomidine + sufentanil for sedation, analgesia and anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022496
Enrollment
Unknown
Registered
2019-04-13
Start date
2019-04-15
Completion date
Unknown
Last updated
2019-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sedation anesthesia surgery patients

Interventions

Group 2:Continuous pumping of dexmedetomidine + remifentanil
Group 1:Continuous pumping of dexmedetomidine + sufentanil

Sponsors

Plastic Surgery Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-60 years; 2. The ASA I ~ II grade; 3. Selected patients undergoing plastic surgery under sedation and analgesia anesthesia.

Exclusion criteria

Exclusion criteria: 1. Abnormal liver and kidney function before operation; 2. Preoperative acute and chronic pain (such as chronic low back and leg pain, migraine, etc.), and took analgesics within 48 hours; 3. Body mass index >30; 4. Having organic congenital heart disease or arrhythmia, hypertension; 5. Had severe lung disease in the past month, such as cystic fibrosis, pulmonary fibrosis, pneumonia.

Design outcomes

Primary

MeasureTime frame
VAS;—

Countries

China

Contacts

Public ContactWang Ye

Plastic Surgery Hospital, Chinese Academy of Medical Sciences

wangyedeemail@126.com+86 15801597504

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026